Basaloid Squamous Cell Carcinoma of the Head and Neck: Subclassification into Basal, Ductal, and Mixed Subtypes Based on Comparison of Clinico-pathologic Features and Expression of p53, Cyclin D1, Epidermal Growth Factor Receptor, p16, and Human Papillomavirus
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Basaloid squamous cell carcinoma (BSCC) is a rare variant of squamous cell carcinoma with distinct pathologic characteristics. The histogenesis of BSCC is not fully understood, and the cancer has been suggested to originate from a totipotent primitive cell in the basal cell layer of the surface epithelium or in the proximal duct of secretory glands. Methods: Twenty-six cases of head and neck BSCC from Asan Medical Center, Seoul, Korea, reported during a 14-year-period were subclassified into basal, ductal, and mixed subtypes according to the expression of basal (cytokeratin [CK] 5/6, p63) or ductal markers (CK7, CK8/18). The cases were also subject to immunohistochemical study for CK19, p53, cyclin D1, epidermal growth factor receptor (EGFR), and p16 and to in situ hybridization for human papillomavirus (HPV), and the results were clinico-pathologically compared. Results: Mixed subtype (12 cases) was the most common, and these cases showed hypopharyngeal predilection, older age, and higher expression of CK19, p53, and EGFR than other subtypes. The basal subtype (nine cases) showed frequent comedo-necrosis and high expression of cyclin D1. The ductal subtype (five cases) showed the lowest expression of p53, cyclin D1, and EGFR. A small number of p16- and/or HPV-positive cases were not restricted to one subtype. BSCC was the cause of death in 19 patients, and the average follow-up period for all patients was 79.5 months. Overall survival among the three subtypes was not significantly different. Conclusions: The results of this study suggest a heterogeneous pathogenesis of head and neck BSCC. Each subtype showed variable histology and immunoprofiles, although the clinical implication of heterogeneity was not determined in this study.
Abstract
Background: Basaloid squamous cell carcinoma (BSCC) is a rare variant of squamous cell carcinoma with distinct pathologic characteristics. The histogenesis of BSCC is not fully understood, and the cancer has been suggested to originate from a totipotent primitive cell in the basal cell layer of the surface epithelium or in the proximal duct of secretory glands. Methods: Twenty-six cases of head and neck BSCC from Asan Medical Center, Seoul, Korea, reported during a 14-year-period were subclassified into basal, ductal, and mixed subtypes according to the expression of basal (cytokeratin [CK] 5/6, p63) or ductal markers (CK7, CK8/18). The cases were also subject to immunohistochemical study for CK19, p53, cyclin D1, epidermal growth factor receptor (EGFR), and p16 and to in situ hybridization for human papillomavirus (HPV), and the results were clinico-pathologically compared. Results: Mixed subtype (12 cases) was the most common, and these cases showed hypopharyngeal predilection, older age, and higher expression of CK19, p53, and EGFR than other subtypes. The basal subtype (nine cases) showed frequent comedo-necrosis and high expression of cyclin D1. The ductal subtype (five cases) showed the lowest expression of p53, cyclin D1, and EGFR. A small number of p16- and/or HPV-positive cases were not restricted to one subtype. BSCC was the cause of death in 19 patients, and the average follow-up period for all patients was 79.5 months. Overall survival among the three subtypes was not significantly different. Conclusions: The results of this study suggest a heterogeneous pathogenesis of head and neck BSCC. Each subtype showed variable histology and immunoprofiles, although the clinical implication of heterogeneity was not determined in this study.
참고문헌 (22)
- Cho KJ, "Basaloid squamous carcinoma of the oesophagus: a distinct neoplasm with multipotential differentiation", Histopathology, 36, pp.331~340 (2000)
- Raslan WF, "Basaloid squamous cell carcinoma of the head and neck: a clinicopathologic and flow cytometric study of 10 new cases with review of the English literature", Am J Otolaryngol, 15, pp.204~211 (1994)
- Kobayashi Y, "Histological diversity in basaloid squamous cell carcinoma of the esophagus", Dis Esophagus, 22, pp.231~238 (2009)
- Imamhasan A, "Immunohistochemical and oncogenetic analyses of the esophageal basaloid squamous cell carcinoma in comparison with conventional squamous cell carcinomas", Hum Pathol, 43, pp.2012~2023 (2012)
- Linskey KR, "BerEp4, cytokeratin 14, and cytokeratin 17 immunohistochemical staining aid in differentiation of basaloid squamous cell carcinoma from basal cell carcinoma with squamous metaplasia", Arch Pathol Lab Med, 137, pp.1591~1598 (2013)
- Mane DR, "Expression of cytokeratin subtypes: MMP-9, p53, and alphaSMA to differentiate basaloid squamous cell carcinoma from other basaloid tumors of the oral cavity", Appl Immunohistochem Mol Morphol, 21, pp.431~443 (2013)
- Patil DT, "Clinicopathological analysis of basal cell carcinoma of the anal region and its distinction from basaloid squamous cell carcinoma", Mod Pathol, 26, pp.1382~1389 (2013)
- Winters R, "Ber-EP4, CK1, CK7 and CK14 are useful markers for basaloid squamous carcinoma: a study of 45 cases", Head Neck Pathol, 2, pp.265~271 (2008)
- Serrano MF, "Utility of high molecular weight cytokeratins, but not p63, in the differential diagnosis of neuroendocrine and basaloid carcinomas of the head and neck", Hum Pathol, 39, pp.591~598 (2008)
- Coletta RD, "Cytokeratins 1, 7 and 14 immunoexpression are helpful in the diagnosis of basaloid squamous carcinoma", Histopathology, 48, pp.773~774 (2006)
- Coletta RD, "Basaloid squamous carcinoma of oral cavity: a histologic and immunohistochemical study", Oral Oncol, 38, pp.723~729 (2002)
- Tsubochi H, "Immunohistochemical study of basaloid squamous cell carcinoma, adenoid cystic and mucoepidermoid carcinoma in the upper aerodigestive tract", Anticancer Res, 20, pp.1205~1211 (2000)
- Xie S, "Basaloid squamous cell carcinoma of the maxillary gingiva : a case report and review of the literature", Oncol Le, 8, pp.1287~1290 (2014)
- Yu GY, "Aclinicopathologic study on basaloid squamous cell carcinoma in the oral and maxillofacial region", Int J Oral Maxillofac Su, 37, pp.1003~1008 (2008)
- Sampaio-Góes FC, "Expression of PCNA, p53, Bax, and Bcl-X in oral poorly differentiated and basaloid squamous cell carcinoma: relationships with prognosis", Head Neck, 27, pp.982~989 (2005)
- Sato-Kuwabara Y, "Comparative analysis of basaloid and conventional squamous cell carcinomas of the esophagus : prognostic relevance of clinicopathological features and protein expression", Tumour Biol, 37, pp.6691~6699 (2016)
- Abe K, "Basaloidsquamous carcinoma of the esophagus: a clinicopathologic, DNA ploidy, and immunohistochemical study of seven cases", Am J Surg Pathol, 20, pp.453~461 (1996)
- MendelsohnAH, "Histopathologic findings of HPV and p16 positive HNSCC", Laryngoscope, 120, pp.1788~1794 (2010)
- El-Mofty SK, "Human papillomavirus (HPV)-related oropharyngeal nonkeratinizing squamous cell carcinoma: characterization of a distinct phenotype", Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 101, pp.339~345 (2006)
- Begum S, "Basaloid squamous cell carcinoma of the head and neck is a mixed variant that can be further resolved by HPV status", Am J Surg Pathol, 32, pp.1044~1050 (2008)
- Chernock RD, "Human papillomavirus-positive basaloid squamous cell carcinomas of the upper aerodigestive tract : a distinct clinicopathologic and molecular subtype of basaloid squamous cell carcinoma", Hum Pathol, 41, pp.1016~1023 (2010)
- Santoro A, "deregulation of normal keratinocyte differentiation pattern and high risk-human papilloma virus infection in oral and oropharyngeal squamous cell carcinoma", Infect Agent Cancer, 10, pp.46~ (2015)